Factors of Non-Compliance with a Protocol for Oral Administration of Misoprostol (Angusta(®)) 25 Micrograms to Induce Labor: An Observational Study

We set out to identify factors of non-compliance with a protocol for the oral administration of misoprostol 25 µg (Angusta(®)) every 2 h (up to eight tablets), for the induction of labor (IOL). We conducted a retrospective study on IOL at term, on singleton pregnancies from 2019 to 2021, in a univer...

Descripción completa

Detalles Bibliográficos
Autores principales: Pambet, Mathilde, Delabaere, Amélie, Figuier, Claire, Lambert, Céline, Comptour, Aurélie, Rouzaire, Marion, Gallot, Denis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9964196/
https://www.ncbi.nlm.nih.gov/pubmed/36836056
http://dx.doi.org/10.3390/jcm12041521

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9964196/
https://www.ncbi.nlm.nih.gov/pubmed/36836056
http://dx.doi.org/10.3390/jcm12041521

Ejemplares similares